Tazemetostat

Tazemetostat


Tazemetostat is an orally bioavailable, S-adenosyl-L-methionine–competitive inhibitor of enhancer of zeste homolog 2 in Polycomb Repressive Complex 2, providing sub-20 nM blockade of histone H3-lysine-27 trimethylation and triggering apoptosis in SMARCB1-deleted cancers.

Molecular structure of the compound BP-44055
    • Unit
    • Price
    • Qty
    • 250 MG
    • $120.00
    • 500 MG
    • $210.00
    • 1 G
    • $350.00

Usually ships within 24 hours.


Would you like to inquire about custom quantity?
Inquire